This scientific statement released by the American Heart Association covers noninvasive assessment of limb perfusion, including limitations associated with currently available technology.
Dose-dependent relationship seen in a large national cohort of US veterans.
Further studies are needed to determine the threshold of risk at which it is safe to withhold therapy for prevention of atherosclerotic cardiovascular disease in elderly people.
The increased CVD risk found in women with hypertensive pregnancy disorders was associated with conventional risk factors.
The LIFEtime-perspective CardioVascular Disease model can accurately estimate individual-level prognosis and treatment-effects in terms of improved 10-year risk, lifetime risk, and life-expectancy free of cardiovascular disease.
Prophylactic prevention reduces nonfatal ischemic events but significantly increases nonfatal bleeding events.
Highest risk for cardiovascular disease mortality seen for those with work stress and impaired sleep.
The VTE-BLEED risk score identified patients with pulmonary embolism at risk for in-hospital major
bleeding.
Test has been underused and represents less than 1% of stress tests, study authors say.
New evidence led to development of 2 new recommendations for combination therapy.
